Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques: Evidence that Dendritic Cells are Early and Sustained Targets of Infection

American Journal of Pathology

Volumn 163, Issue 6, 2003, Pages 2347-2370

  Geisbert, Thomas W ^a,d   Hensley, Lisa E ^a   Larsen, Tom ^a   Young, Howard A ^b   Reed, Douglas S ^a   Geisbert, Joan B ^a   Scott, Dana P ^a   Kagan, Elliott ^c   Jahrling, Peter B ^a   Davis, Kelly J ^a  

^a US Army Medical Institute for Infectious Diseases   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BYSTANDER EFFECT; CELL LOSS; CLINICAL FEATURE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; EBOLA VIRUS; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; LYMPHOID TISSUE; MACACA; MALE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; UPREGULATION; VIRUS CELL INTERACTION; VIRUS HEMORRHAGIC FEVER;

EID: 10744224131     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63591-2     Document Type: Article

References (82)

1. Bowen ETW, Lloyd G, Harris WJ, Platt GS, Baskerville A, Vella EE: Viral haemorrhagic fever in southern Sudan and northern Zaire. Lancet 1977, 1:571-573
2. Johnson KM, Lange JV, Webb PA, Murphy FA: Isolation and partial characterization of a new virus causing acute haemorrhagic fever in Zaire. Lancet 1977, 1:569-571
3. Khan AS, Tshioko K, Heymann DL, Le Guenno B, Nabreth P, Kerstiens B, Fleerackers Y, Kilmarx PH, Rodier GR, Nkuku O, Rollin PE, Sanchez A, Zaki SR, Swanepoel R, Tomori O, Nichol ST, Peters CJ, Muyembe-Tamfum JJ, Ksiazek TG: The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J Infect Dis 1999, 179(Suppl 1):S76-S86
4. Bowen ETW, Platt GS, Simpson DIH, McArdell LB, Raymond RT: Ebola haemorrhagic fever: experimental infection of monkeys. Trans R Soc Trop Med Hyg 1978, 72:188-191
5. Fisher-Hoch SP, Brammer LT, Trappier SG, Hutwagner LC, Farrar BB, Ruo SL, Brown BG, Hermann LM, Perez-Oronoz GI, Goldsmith CS, Hanes MA, McCormick JB: Pathogenic potential of filoviruses: role of geographic origin of primate host and virus strain. J Infect Dis 1992, 166:753-763
6. Jaax NK, Davis KJ, Geisbert TW, Vogel P, Jaax GP, Topper M, Jahrling PB: Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med 1996, 120:140-155
7. Geisbert TW, Pushko P, Anderson K, Smith J, Davis KJ, Jahrling PB: Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg Infect Dis 2002, 8:503-507
8. Ryabchikova E, Kolesnikova L, Smolina M, Tkachev V, Pereboeva L, Baranova S, Grazhdantseva A, Rassadkin Y: Ebola virus infection in guinea pigs: presumable role of granulomatous inflammation in pathogenesis. Arch Virol 1996, 141:909-921
9. Bray M, Hatfill S, Hensley L, Huggins JW: Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus. J Comp Pathol 2001, 125:243-253
10. Bray M, Davis K, Geisbert T, Schmaljohn C, Huggins J: A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever J Infect Dis 1998, 178:651-661
11. Connolly BM, Steele KE, Davis KJ, Geisbert TW, Kell WM, Jaax NK, Jahrling PB: Pathogenesis of experimental Ebola virus infection in guinea pigs. J Infect Dis 1999, 179(Suppl 1):S203-S217
12. Murphy FA: Pathology of Ebola virus infection. Ebola Virus Haemorrhagic Fever. Edited by SR Pattyn. New York, Elsevier/North-Holland Biomedical Press, 1978, pp 43-60
13. Zaki SR, Goldsmith CS: Pathologic features of filovirus infections in humans. Curr Top Microbiol Immunol 1999, 235:97-116
14. Davis KJ, Anderson AO, Geisbert TW, Steele KE, Geisbert JB, Vogel P, Connolly BM, Huggins JW, Jahrling PB, Jaax NK: Pathology of experimental Ebola virus infection in African green monkeys. Arch Pathol Lab Med 1997, 121:805-819
15. Jahrling PB, Geisbert J, Swearengen JR, Jaax GP, Lewis T, Huggins JW, Schmidt JJ, LeDuc JW, Peters CJ: Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch Virol 1996, 11(Suppl):135-140
16. Jahrling PB, Geisbert TW, Geisbert JB, Swearengen JR, Bray M, Jaax NK, Huggins JW, LeDuc JW, Peters CJ: Evaluation of immune globulin and recombinant interferon-α2b for treatment of experimental Ebola virus infections. J Infect Dis 1999, 179(Suppl 1):S224-S234
17. Sullivan NJ, Sanchez A, Rollin PE, Yang Z-Y, Nabel GJ: Development of a preventative vaccine for Ebola virus infection in primates. Nature 2000, 408:605-609
18. Fisher-Hoch SP, Platt GS, Neild GH, Southee T, Baskerville A, Raymond RT, Lloyd G, Simpson DIH: Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J Infect Dis 1985, 152:887-894
19. Johnson E, Jaax N, White J, Jahrling P: Lethal experimental infections in rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol 1995, 76:227-236
20. P'yankov OV, Sergeev AN, P'ankova OG, Chepurnov AA: Experimental Ebola fever in macaca rhesus. Vopr Virusol 1995, 40:113-115
21. Mikhailov VV, Borisevich IV, Chernikova NK, Potryvaeva NV, Krasnyanskii VP: An evaluation of the possibility of Ebola fever specific prophylaxis in baboons (Papio hamadryas). Vopr Virusol 1994, 39: 82-84
22. Borisevich IV, Mikhailov VV, Krasnyanskii VP, Gradoboev VN, Lebedinskaya YV, Potryvaeva NV, Timan'kova GD: Creation and study of immunoglobulin to Ebola fever. Vopr Virusol 1995, 40:270-273
23. Chepurnov AA, Chernukhin IV, Ternovoi VA, Kudoiarova NM, Makhova NM, Azaev MSh, Smolina MP: Attempts to develop a vaccine against Ebola fever. Vopr Virusol 1995, 40:257-260
24. Markin VA, Mikhailov VV, Krasnyanskii VP, Borisevich IV, Firsova IV: Development of emergency prophylaxis and treatment of Ebola fever. Vopr Virusol 1997, 42:31-34
25. Kudoyarova-Zubavichene NM, Sergeyev NN, Chepurnov AA, Netesov SV: Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections. J Infect Dis 1999, 179(Suppl 1):S218-S223
26. Ryabchikova EI, Kolesnikova LV, Luchko SV: An analysis of features of pathogenesis in two animal models of Ebola virus infection. J Infect Dis 1999, 179(Suppl 1):S199-S202
27. Prophet EB, Mills B, Arrington JB, Sobin LH: Laboratory Methods in Histotechnology. Washington DC, Armed Forces Institute of Pathology, 1992, pp 25-59
28. Geisbert TW, Hensley LE, Gibb TR, Steele KE, Jaax NK, Jahrling PB: Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest 2000, 80:171-186
29. Jahrling PB: Filoviruses and Arenaviruses. Manual of Clinical Microbiology. Edited by PR Murray, EJ Baron, M Pfaller, FC Tenover, RH Yolken Washington DC, ASM Press, 1999, pp 1125-1136
30. Hensley LE, Young HA, Jahrling PB, Geisbert TW: Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett 2002, 80:169-179
31. Soilleux EJ, Morris LS, Leslie G, Chehimi J, Luo Q, Levroney E, Trowsdale J, Montaner LJ, Doms RW, Weissman D, Coleman N, Lee B: Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol 2002, 41:445-457
32. Geisbert TW, Jahrling PB: Differentiation of filoviruses by electron microscopy Virus Res 1995, 39:129-150
33. Moschella SL, Cropley TG: Mononuclear phagocytic and dendritic cell systems. J Am Acad Dermatol 1990, 22:1091-1097
34. Wacker HH, Radzun HJ, Parwaresch MR: Accessory cells in normal human and rodent lymph nodes: morphology, phenotype, and functional implications. Curr Top Pathol 1990, 84:193-218
35. Steele K, Crise B, Kuehne A, Kell W: Ebola virus glycoprotein demonstrates differential cellular localization in infected cell types of nonhuman primates and guinea pigs. Arch Pathol Lab Med 2001, 125:625-630
36. Majno G, Joris I: Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol 1995, 146:3-15
37. Granville DJ, Carthy CM, Hunt DWC, McManus BM: Apoptosis: molecular aspects of cell death and disease. Lab Invest 1998, 78:893-913
38. Ferrarini M, Grossi CE: Ultrastructure and cytochemistry of the human large granular lymphocytes. Immunobiology of Natural Killer Cells. Edited by E Lotzova, RB Herberman. Boca Raton, CRC Press, 1986, pp 34-50
39. Neighbour PA, Huberman HS, Kress Y: Human large granular lymphocytes and natural killing: ultrastuctural studies of strontium-induced degranulation. Eur J Immunol 1982, 588-595
40. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Larsen T, Kagan E, Hensley LE: Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not the direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol 2003, 163:2371-2382
41. Geisbert TW, Jahrling PB, Hanes MA, Zack PM: Association of Ebola related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States. J Comp Pathol 1992, 106:137-152
42. Baumann H, Gauldie J: The acute phase response. Immunol Today 1994, 15:74-89
43. Feldmann H, Bugany H, Mahner F, Klenk H-D, Drenckhahn D, Schnittier H-J: Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol 1996, 70:2208-2214
44. Stroher U, West E, Bugany H, Klenk HD, Schnittler HJ, Feldmann H: Infection and activation of monocytes by Marburg and Ebola viruses. J Virol 2001, 75:11025-11033
45. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811
46. Stingl G, Bergstresser PR: Dendritic cells: a major story unfolds. Immunol Today 1995, 16:330-333
47. Larsen CP, Steinman RM, Witmer-Pack M, Hankins DF, Morris PJ, Austyn JM: Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 1990, 172:1483-1493
48. Inaba K, Metlay JP, Crowley MT, Steinman RM: Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med 1990, 172:631-640
49. Macatonia SE, Gompels M, Pinching AJ, Patterson S, Knight SC: Antigen-presentation by macrophages but not by dendritic cells in human immunodeficiency virus (HIV) infection. Immunology 1992, 75:576-581
50. Blauvelt A, Clerici M, Lucey DR, Streinberg SM, Yarchoan R, Walker R, Shearer GM, Katz SI: Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons. J Immunol 1995, 154:3506-3515
51. + T Cells. J Exp Med 1997, 186: 801-812
52. Fugier-Vivier I, Servet-Delprat C, Rivailler P, Rissoan M-C, Liu Y-J, Rabourdin-Combe C: Measles virus suppresses cell-mediated immunity by interfering with the survival and function of dendritic and T cells. J Exp Med 1997, 186:813-823
53. Schnorr J-J, Xanthakos S, Keikavoussi P, Kampgen E, ter Meulen V, Schneider-Schaulies S: Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci 1997, 94:5326-5331
54. Sevilla N, Kunz S, Holz A, Lewicki H, Homann D, Yamada H, Campbell KP, de la Torre JC, Oldstone MB: Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J Exp Med 2000, 192:1249-1260
55. Ho L-J, Wang J-J, Shaio M-F, Kao C-L, Chang D-H, Han S-W, Lai J-H: Infection of human dendritic cells by dengue viruses causes cell maturation and cytokine production. J Immunol 2001, 166: 1499-1506
56. Raftery MJ, Schwab M, Eibert SM, Samstag Y, Walczak H, Schonrich G: Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 2001, 15:997-1009
57. Kruse M, Rosorius O, Kratzer F, Stelz G, Kuhnt C, Schuler G, Hauber J, Steinkasserer A: Mature dendritic cells infected with herpes simplex virus type 1 exhibited inhibited T-cell stimulatory capacity. J Virol 2000, 74:7127-7136
58. Bukreyev A, Volchkov VE, Blinov VM, Netesov SV: The GP-protein of Marburg virus contains the region similar to the 'immunosuppressive domain' of oncogenic retrovirus P15E proteins. FEBS Lett 1993, 323: 183-187
59. Sanchez A, Kiley MP, Holloway BP, Auperin DD: Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res 1993, 29:215-240
60. Sanchez A, Trappier SG, Mahy BW, Peters CJ, Nichol ST: The virion glycoproteins of Ebola viruses are encoded in two reading frames and are exposed through transcriptional editing. Proc Natl Acad Sci USA 1996, 93:3602-3607
61. Baize S, Leroy. EM, Georges-Courbot M-C, Capron M, Lansoud-Soukate J, Debre P, Fisher-Hoch SP, McCormick JB, Georges AJ: Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 1999, 5:423-426
62. Baize S, Leroy EM, Mavoungou E, Fisher-Hoch SP: Apoptosis in fatal Ebola infection. Does the virus toll the bell for immune system? Apoptosis 2000, 5:5-7
63. Andrade F, Bull HG, Thornberry NA, Ketner GW, Casciola-Rosen LA, Rosen A: Adenovirus L4-100K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death. Immunity 2001, 14:751-761
64. Kayagaki N, Yamaguchi N, Nakayama M, Eto H, Okumura K, Yagita H: Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I INFs. J Exp Med 1999, 189;1451-1460
65. Dhib-Jalbut SS, Cowan EP: Direct evidence that interferon-beta mediates enhanced HLA-class I expression in measles virus-infected cells. J Immunol 1993, 151:6248-6258
66. Griffith TS, Wiley SR, Kubin MZ, Sedger LM, Maliszewski CR, Fanger NA: Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine. TRAIL J Exp Med 1999, 189:1343-1353
67. Vidalain P-O, Azocar O, Lamouille B, Astier A, Rabourdin-Combe C, Servet-Delpart C: Measles virus induces functional TRAIL production by human dendritic cells. J Virol 2000, 74:556-559
68. Beaulieu S, Lafontaine M, Richer M, Courchesne I, Cohen EA, Bergeron D: Characterization of the cytotoxic factor(s) released from thymic dendritic cells upon human immunodeficiency virus type 1 infection. Virology 1998, 241:285-297
69. Katsikis PD, Garcia-Ojeda ME, Torres-Roca JF, Tijoe IM, Smith CA, Herzenberg LA, Herzenberg LA: Interleukin-1 β converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection: TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection. J Exp Med 1997, 186:1365-1372
70. Jeremias I, Herr I, Boehler T, Debatin KM: TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Eur J Immunol 1998, 28:143-152
71. Pavlovic J, Arzet HA, Hefti HP, Frese M, Rost D, Ernst B, Kolb E, Staeheli P, Haller O: Enhanced virus resistance of transgenic mice expressing the human MxA protein. J Virol 1995, 69:4506-4510
72. Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavecchia A: Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med 1999, 189:821-829
73. Wong BR, Josien R, Lee SY, Sauter B, Li HL, Steinman RM, Choi Y: TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 1997, 186:2075-2080
74. Yeh WC, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, de la Pompa JL, Ferrick D, Hum B, Iscove N, Ohashi P, Rothe M, Goeddel DV, Mak TW: Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 1997, 7:715-725
75. Takabayashi A, Kawai Y, Iwata S, Kanai M, Denno R, Kawada K, Obama K, Taki Y: Nitric oxide induces a decrease in the mitochondrial membrane potential of peripheral blood lymphocytes, especially in natural killer cells. Antioxid Redox Signal 2000, 2:673-680
76. Villinger F, Rollin PE, Brar SS, Chikkala NF, Winter J, Sundstrom JB, Zaki SR, Swanepoel R, Ansari AA, Peters CJ: Markedly elevated levels of interferon (IFN)-α, IFN-γ interleukin (IL)-2, IL-10, and tumor necrosis factor-α associated with fatal Ebola virus infection. J Infect Dis 1999, 179(Suppl 1):S188-S191
77. Bailly S, Fay M, Gougerot-Pocidalo MA: Effects of antibiotics on production of cytokines by human monocytes. Pathol Biol (Paris) 1993, 41:838-844
78. Morikawa K, Watabe H, Araake M, Morikawa S: Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrob Agents Chemother 1996, 40:1366-1370
79. van Vlem B, Vanholder R, de Paepe P, Vogelaers D, Ringoir S: Immunomodulating effects of antibiotics: a literature review. Infection 1996, 24:275-291
80. Khan AA, Slifer TR, Araujo FG, Remington JS: Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. Int J Antimicrob Agents 1999, 11:121-132
81. Guo W, Ding J, Huang Q, Jerrels T, Deitch EA: Alterations in intestinal bacterial flora modulate the systemic cytokine response to hemorrhagic shock. Am J Physiol 1995, 269:G827-G832
82. Guo W, Magnotti LJ, Ding J, Huang Q, Xu D, Deitch EA: Influence of gut microflora on mesenteric lymph cytokine production in rats with hemorrhagic shock. J Trauma 2002, 52:1178-1185